The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Kane Biotech Inc

Venture: KNE
Delayed quote

$0.03

Today's change0.00 0.00%
Updated September 23 12:00 AM EDT. Delayed by at least 15 minutes.
 

Kane Biotech Inc

Venture: KNE
Delayed quote

$0.03

Today's change0.00 0.00%
Updated September 23 12:00 AM EDT. Delayed by at least 15 minutes.

Kane Biotech Inc unchanged

Kane Biotech Inc closed unchanged Friday sitting at $0.03. Although unchanged over the last five days, shares are down 50.00% for the last year to date. This security has underperformed the S&P TSX by 25.94% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated January 1 -- EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1,599.15%

Although this company's net profit margin is negative, it is above the industry average and implies that Kane Biotech Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.53%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense1100
Selling / general / administrative1100
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income-1-100
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets----00
Other--------
Income before tax-1-100
Income after tax-1-100
Income tax, total--------
Net income-1-100
Total adjustments to net income--------
Net income before extra. items-1-100
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-100
Inc. avail. to common incl. extra. items-1-100
Diluted net income-1-100
Dilution adjustment--------
Diluted weighted average shares149120114108
Diluted EPS excluding extraordinary itemsvalue per share-0.010.000.000.00
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.010.000.000.00